Legal & General Group
DMTK

Legal & General Group’s DermTech, Inc. Common Stock DMTK Stock Holding History

Legal & General Group’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,664
Closed -$30K – 3438
2022
Q3 		$30K Sell
7,664
-15,515
-67% -$95.4K ﹤0.01% 3106
2022
Q2 		$129K Buy
23,179
+13,378
+136% +$110K ﹤0.01% 2784
2022
Q1 		$143K Hold
9,801
– – ﹤0.01% 2781
2021
Q4 		$155K Buy
9,801
+35
+0.4% +$841 ﹤0.01% 2804
2021
Q3 		$313K Buy
9,766
+3,483
+55% +$122K ﹤0.01% 2553
2021
Q2 		$261K Buy
6,283
+4,618
+277% +$190K ﹤0.01% 2474
2021
Q1 		$85K Buy
1,665
+652
+64% +$34.1K ﹤0.01% 2662
2020
Q4 		$33K Hold
1,013
– – ﹤0.01% 2920
2020
Q3 		$12K Sell
1,013
-313
-24% -$3.63K ﹤0.01% 3177
2020
Q2 		$18K Buy
+1,326
New +$17.3K ﹤0.01% 3116

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's DMTK Position: Q4 2022 in Review

Legal & General Group sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 7,664 shares — an estimated $30K sold.

Legal & General Group first reported a position in DMTK in Q2 2020 and held it in 10 quarters. The position peaked at $313K in Q3 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • Legal & General Group reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 7,664 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $30K.
  • Legal & General Group first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Legal & General Group's DermTech, Inc. Common Stock position peaked at $313K in Q3 2021.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.